C.S. Mott Children's Hospital is a pediatric acute care hospital located in Ann Arbor, Michigan. The hospital has 244 pediatric beds and is affiliated with the University of Michigan Medical School.

There are 348 beds in C.S. Mott Children's Hospital.

During the past decade, C.S. Mott Children's Hospital conducted 165 clinical trials. In the 10-year time frame, 165 clinical trials started and 111 clinical trials were completed, i.e. on average, 67.3% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 47 clinical trials were completed. i.e. 82.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "C.S. Mott Children's Hospital" #1 sponsor was "Children's Oncology Group" with 152 trials, followed by "National Cancer Institute (NCI)" with 81 trials sponsored, "University of Michigan" with 20 trials sponsored, "Therapeutic Advances in Childhood Leukemia Consortium" with 12 trials sponsored and "New Approaches to Neuroblastoma Therapy Consortium" with 12 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "C.S. Mott Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 158 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 16 trials as a collaborator, "Children's Oncology Group" with 11 trials as a collaborator, "Children's Hospital Los Angeles" with 9 trials as a collaborator and "Seattle Children's Hospital" with 8 trials as a collaborator. Other collaborators include 284 different institutions and companies that were collaborators in the rest 172 trials.

According to Clinical.Site data, the most researched conditions in "C.S. Mott Children's Hospital" are "Neuroblastoma" (32 trials), "Recurrent Malignant Solid Neoplasm" (29 trials), "Recurrent Neuroblastoma" (29 trials), "Refractory Malignant Solid Neoplasm" (28 trials) and "Recurrent Osteosarcoma" (21 trials). Many other conditions were trialed in "C.S. Mott Children's Hospital" in a lesser frequency.

Most popular intervention types in "C.S. Mott Children's Hospital" are "Drug" (270 trials), "Other" (148 trials), "Procedure" (94 trials), "Biological" (89 trials) and "Radiation" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Cyclophosphamide" (49 trials), "Pharmacological Study" (41 trials), "Vincristine Sulfate" (38 trials) and "Cytarabine" (33 trials). Other intervention names were less common.

The vast majority of trials in "C.S. Mott Children's Hospital" are 368 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "C.S. Mott Children's Hospital". undefined are not yet recruiting, 77 are recruiting, 94 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 182 completed trials in C.S. Mott Children's Hospital, 5 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in C.S. Mott Children's Hospital, 97 "Phase 1" clinical trials were conducted, 123 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 35 trials that are defined as “Not Applicable".

C.S. Mott Children's Hospital has several departments that took part in Clinical trials: "University of Michigan Congenital Heart Center" - 6 trials